SQY51
/ SQY Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 08, 2023
AVANCE1: Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy
(clinicaltrials.gov)
- P1/2 | N=12 | Recruiting | Sponsor: Sqy Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • Duchenne Muscular Dystrophy • Genetic Disorders • Muscular Dystrophy • Pediatrics
March 03, 2023
AVANCE1: Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy
(clinicaltrials.gov)
- P1/2 | N=12 | Not yet recruiting | Sponsor: Sqy Therapeutics
New P1/2 trial • Duchenne Muscular Dystrophy • Genetic Disorders • Muscular Dystrophy • Pediatrics
1 to 2
Of
2
Go to page
1